Cite

HARVARD Citation

    Azie, N. et al. (2020). Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis. Expert opinion on investigational drugs. pp. 893-900. [Online]. 
  
Back to record